McMaster University

McMaster University

The Pedi FETCh Research Trial

The Pedi FETCh Research Trial: Pediatric Fecal Transplant for Ulcerative Colitis (FETCh)

The Pedi FETCh Research Trial (Pediatric Fecal Transplant for Ulcerative Colitis) is the first pediatric fecal transplant study for inflammatory bowel disease in Canada, and will be the first randomized controlled trial of fecal transplant in pediatric inflammatory bowel disease in the world. The trial is being lead by Dr. Nikhil Pai, and supported by the Division of Pediatric Gastroenterology and Nutrition at McMaster Children’s Hospital. Study collaborators include Dr. Christine Lee (Division of Infectious Disease at St. Joseph's Hospital in Hamilton), and Paul Moayyedi (Division of Adult Gastroenterology at McMaster University), with support from the Farncombe Digestive Disease Research Institute at McMaster University.

What's Involved?

The Pedi FETCh study is a single blind, placebo controlled, randomized controlled trial. Twice a week for six weeks, participants will come to McMaster Children’s Hospital 3E Clinic to receive a fecal retention enema containing live, safety screened, human donor stool, or a placebo containing normal saline. Twelve enemas will be given over the course of six weeks. Patients will remain on their existing medications and current doses for the duration of the trial.

Clinic Location:

Pedi FETCh Research Trial
3E Clinic (3rd Floor)
McMaster Children's Hospital
1200 Main Street West
Hamilton, Ontario

Valid XHTML 1.0 Transitional Level Double-A conformance, W3C WAI Web Content Accessibility Guidelines 2.0